Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives

Table 5 The difference in costs per year between CKD stages from the societal perspective

	CKD stages 1–2 N = 15	CKD stages 3a-3b N = 42	CKD stages 4–5 N = 45	p-value*
Cost of medications
Median (IQR)	1,440,000 (756,000–2,016,000)	2,292,000 (1,797,000–3,657,500)	3,500,000 (2,115,000–5,749,500)	< 0.001
Cost of ESA
Median (IQR)	0	0 (0–0)	0 (0–1,440,000)	< 0.001
Cost of blood tests
Median (IQR)	450,000 (230,000–650,000)	535,000 (345,000–734,750)	690,000 (505,000–900,000)	0.004
Cost of radiology
Median (IQR)	0 (0–137,000)	0 (0–62,500)	0 (0–85,000)	0.759
Cost of hospitalizations
Median (IQR)	0 (0–800,000)	0 (0–134,000)	0 (0–1,800,000)	0.347
Cost of physicians
Median (IQR)	100,000 (50,000–170,000)	100,000 (50,000–200,000)	160,000 (50,000–245,000)	0.126
Cost of transportation
Median (IQR)	20,000 (20,000–40,000)	40,000 (20,000–60,000)	50,000 (40,000–100,000)	0.002
Total cost
Median (IQR)	2,382,000 (1,320,000–4,843,000)	4,281,500 (2,600,250–4,991,000)	5,794,520 (3,556,500–8,628,000)	0.019

ISSN: 1472-6963